Genetic engineering of Escherichia coli for the production of precorrin-3 in vivo and in vitro

Add time:08/25/2019    Source:sciencedirect.com

The construction of a new recombinant strain of Escherichia coli in which two vitamin B12 biosynthetic genes, cobA and cobI, from Pseudomonas denitrificans are simultaneously overexpressed has resulted in the in vivo synthesis and accumulation of Factor III, an isobacteriochlorin not normally synthesized in E. coli. A lysate of the new strain can take the place of two lysates normally required to provide uroporphyrinogen III methyltransferase (cobA) and precorrin-2 methyltransferase (cobI) in an anaerobic five-enzyme synthesis of the early B12 intermediate, precorrin-3 (the reduced form of Factor III) from δ-aminolevulinic acid.

We also recommend Trading Suppliers and Manufacturers of precorrin 3 (cas 114019-24-8). Pls Click Website Link as below: cas 114019-24-8 suppliers

Prev:Electronic spectra of coumarin-151 in polar solvents: Linear response free energy approach
Next:Crystallization noteThe crystal structure of putative precorrin isomerase CbiC in cobalamin biosynthesis)